The Clorox Company
CLXNYSEConsumer Defensive● Active
$95.46
+$1.32(+1.40%)
Market Cap$11.5B
P/E Ratio—
52W High$132.03
52W Low$84.7
The Clorox Company (CLX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CLX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$1.64
Est. $1.54 · +6.5%
Revenue
$1.67B
Est. $1.67B · +0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
CLX reports quarterly as a NYSE-listed Household & Personal Products company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.27B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.27B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $1.66 | — | — | — | $1.91B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $1.54 | $1.64 | +6.5% | $1.67B | $1.67B | +0.1% |
| ▼ Q1 FY2026 | Feb 3, 2026 | $1.43 | $1.39 | -2.8% | $1.67B | $1.64B | +2.0% |
| ▲ Q4 FY2025 | Nov 3, 2025 | $0.82 | $0.85 | +3.9% | $1.43B | $1.40B | +2.1% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $2.20 | $2.87 | +30.4% | $1.99B | $1.93B | +3.1% |
| ▼ Q2 FY2025 | May 5, 2025 | $1.55 | $1.45 | -6.5% | $1.67B | $1.72B | -2.8% |
| ▲ Q1 FY2025 | Feb 3, 2025 | $1.39 | $1.55 | +11.5% | $1.69B | $1.76B | -4.3% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $1.41 | $1.86 | +31.9% | $1.76B | $1.65B | +6.9% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$1.66
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$1.64
EPS Est.
$1.54
EPS Surpr.
+6.5%
Revenue
$1.67B
Q1 FY2026
Feb 3, 2026Miss
EPS Actual
$1.39
EPS Est.
$1.43
EPS Surpr.
-2.8%
Revenue
$1.67B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
$0.85
EPS Est.
$0.82
EPS Surpr.
+3.9%
Revenue
$1.43B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$2.87
EPS Est.
$2.20
EPS Surpr.
+30.4%
Revenue
$1.99B
Q2 FY2025
May 5, 2025Miss
EPS Actual
$1.45
EPS Est.
$1.55
EPS Surpr.
-6.5%
Revenue
$1.67B
Q1 FY2025
Feb 3, 2025Beat
EPS Actual
$1.55
EPS Est.
$1.39
EPS Surpr.
+11.5%
Revenue
$1.69B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$1.86
EPS Est.
$1.41
EPS Surpr.
+31.9%
Revenue
$1.76B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $1.81 | $1.88 | $1.93 | 6 |
| Q1 FY2028 | $1.58 | $1.64 | $1.68 | 4 |
| Q4 FY2027 | $1.51 | $1.56 | $1.60 | 6 |
| Q3 FY2027 | $1.42 | $1.47 | $1.51 | 3 |
| Q2 FY2027 | $1.72 | $1.79 | $1.83 | 5 |
| Q1 FY2027 | $1.64 | $1.70 | $1.74 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $1.9B | $2.0B | $2.0B | 1 |
| Q1 FY2028 | $1.9B | $1.9B | $2.0B | 1 |
| Q4 FY2027 | $1.9B | $1.9B | $2.0B | 2 |
| Q3 FY2027 | $1.9B | $2.0B | $2.0B | 2 |
| Q2 FY2027 | $1.9B | $2.0B | $2.0B | 2 |
| Q1 FY2027 | $1.8B | $1.9B | $1.9B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +6.5% | $94.77 | $96.44 | +1.76% |
| ▼ Q1 FY2026 | Feb 3, 2026 | -2.8% | $113.29 | $114.98 | +1.49% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +3.9% | $112.46 | $109.14 | -2.95% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +30.4% | $126.18 | $125.56 | -0.49% |
| ▼ Q2 FY2025 | May 5, 2025 | -6.5% | $139.08 | $138.39 | -0.50% |
| ▲ Q1 FY2025 | Feb 3, 2025 | +11.5% | $158.68 | $159.78 | +0.69% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +31.9% | $156.83 | $156.51 | -0.20% |
| ▲ Q3 FY2024 | Aug 1, 2024 | +16.7% | $131.93 | $134.14 | +1.68% |
Q2 FY2026+1.76%
Report Date
Apr 30, 2026
EPS Beat/Miss
+6.5%
Price Before
$94.77
Price After
$96.44
Q1 FY2026+1.49%
Report Date
Feb 3, 2026
EPS Beat/Miss
-2.8%
Price Before
$113.29
Price After
$114.98
Q4 FY2025-2.95%
Report Date
Nov 3, 2025
EPS Beat/Miss
+3.9%
Price Before
$112.46
Price After
$109.14
Q3 FY2025-0.49%
Report Date
Jul 31, 2025
EPS Beat/Miss
+30.4%
Price Before
$126.18
Price After
$125.56
Q2 FY2025-0.50%
Report Date
May 5, 2025
EPS Beat/Miss
-6.5%
Price Before
$139.08
Price After
$138.39
Q1 FY2025+0.69%
Report Date
Feb 3, 2025
EPS Beat/Miss
+11.5%
Price Before
$158.68
Price After
$159.78
Q4 FY2024-0.20%
Report Date
Oct 30, 2024
EPS Beat/Miss
+31.9%
Price Before
$156.83
Price After
$156.51
Q3 FY2024+1.68%
Report Date
Aug 1, 2024
EPS Beat/Miss
+16.7%
Price Before
$131.93
Price After
$134.14
Avg Beat Reaction+0.08%
Avg Miss Reaction+0.49%
Beat Rate6 / 8 quarters
Largest Move-2.95% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CLX ends December
The Clorox Company (CLX) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $1.64 — beating the analyst consensus of $1.54 by +6.5%. The next CLX earnings date is expected around September 1, 2026.
Each quarter, investors track CLX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CLX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CLX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CLX earnings · 5 questionsThe Clorox Company's next earnings report is expected around September 1, 2026. CLX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CLX historically reports after market close (AMC).
CLX earnings datewhen is CLX earningsCLX next earnings datewhen does CLX report earningsCLX earnings calendar
▸ Source: FMP · The Clorox Company SEC filings · US GAAP · The Clorox Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026